A prospective cohort study to explore effective treatment preventing respiratory function decline in asthmatic children with medium-dose inhaled corticosteroid therapy.

A prospective cohort study to explore effective treatment preventing respiratory function decline in asthmatic children with medium-dose inhaled corticosteroid therapy. - A prospective cohort study to explore effective treatment preventing respiratory function decline in asthmatic children with medium-dose inhaled corticosteroid therapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050416

Enrollment

100

Registered

2023-02-25

Start date

2023-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Asthmatic children between 6 and 16 years of age who are treated by Step 3 long-term management of Japanese guideline. 2) Those whose FEV1, FEV1/FVC, and V50 have been measured at least once a year, and at least 3 times in the last 2 years

Exclusion criteria

Exclusion criteria: 1) Patients who are treating or have ever treated by biologics 2) Those who have requested to opt out of this study 3) Those who are deemed by the Principal Investigator or Principal Investigator to be inappropriate for participation in this study.

Design outcomes

Primary

Measure	Time frame
Changes in respiratory function by therapeutic agent	—

Secondary

Measure	Time frame
1. changes in asthma control 2. Biomarker changes 3. confirmation of the presence or absence of growth suppression	—

Countries

Japan

Contacts

Public ContactTakahiro Nishida

National Mie Hospital Department of Pediatrics and Allergy

t_nishida0930@yahoo.co.jp0592322531

Outcome results